Thomas Reed

Track

Insider profile

Currently holds a position at Precigen Inc

Performance

Overall performance
2.2
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -17% 8.2% 15.1%
Success rate 4% 68% 82%
Transactions
9 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 33%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Founder, Chief Science Officer Precigen Inc Jan. 1, 2016 -
Chief Science Officer Precigen Inc April 16, 2014 - Jan. 1, 2016
Chief Science Officer, Director Precigen Inc Jan. 1, 1998 - April 16, 2014
Thomas Reed's trades of Helios Towers PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
266.15
Quantity 71,461
Value £1,169,933
Transaction date
Purchase
Price
424.51
Quantity 38,405
Value £310,677
Transaction date
Purchase
Price
180.92
Quantity 3,866
Value £2,936,897
Transaction date
Purchase
Price
1.52
Quantity 14,519
Value £22,098
US Precigen Inc (PGEN)
Transaction date
Planned sale
Price
5.83
Quantity 5,416 -3.5%
Value US$31,571
US Precigen Inc (PGEN)
Transaction date
Planned sale
Price
5.77
Quantity 2,986 -2.2%
Value US$17,229
US Precigen Inc (PGEN)
Transaction date
Planned sale
Price
5.60
Quantity 3,533 -2.7%
Value US$19,785
US Precigen Inc (PGEN)
Transaction date
Planned sale
Price
5.50
Quantity 3,658 -3.0%
Value US$20,104
US Precigen Inc (PGEN)
Transaction date
Planned sale
Price
7.76
Quantity 3,527 -3.2%
Value US$27,370
US Precigen Inc (PGEN)
Transaction date
Sale
Price
4.66
Quantity 2,300 -5.2%
Value US$10,718
US Precigen Inc (PGEN)
Transaction date
Sale
Price
4.22
Quantity 44,000 -50.0%
Value US$185,680
US Precigen Inc (PGEN)
Transaction date
Sale
Price
4.17
Quantity 165,000 -65.2%
Value US$688,050
US Precigen Inc (PGEN)
Transaction date
Sale
Price
4.24
Quantity 16,500 -20.8%
Value US$69,960
US Precigen Inc (PGEN)
Transaction date
Planned sale
Price
7.07
Quantity 2,944 -3.6%
Value US$20,816
US Precigen Inc (PGEN)
Transaction date
Sale
Price
6.36
Quantity 30,000 -29.2%
Value US$190,671
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-26 2026-03-24
S Sale
71,461
266.15
£1,169,933 		71,461 266.15 £1,169,933
2026-03-16 2026-03-13
B Purchase
38,405
424.51
£310,677 		38,405 424.51 £310,677
2024-03-15 2024-03-14
B Purchase
3,866
180.92
£2,936,897 		3,866 180.92 £2,936,897
2021-03-19 2021-03-18
B Purchase
14,519
1.52
£22,098 		14,519 1.52 £22,098
2020-01-07 2020-01-06
US Precigen Inc (PGEN)
PlS Planned sale
5,416 -3.5%
5.83
US$31,571 		5,416 -3.5% 5.83 US$31,571
2020-01-06 2020-01-03
US Precigen Inc (PGEN)
PlS Planned sale
2,986 -2.2%
5.77
US$17,229 		2,986 -2.2% 5.77 US$17,229
2020-01-03 2020-01-02
US Precigen Inc (PGEN)
PlS Planned sale
3,533 -2.7%
5.60
US$19,785 		3,533 -2.7% 5.60 US$19,785
2019-10-02 2019-10-01
US Precigen Inc (PGEN)
PlS Planned sale
3,658 -3.0%
5.50
US$20,104 		3,658 -3.0% 5.50 US$20,104
2019-07-02 2019-07-01
US Precigen Inc (PGEN)
PlS Planned sale
3,527 -3.2%
7.76
US$27,370 		3,527 -3.2% 7.76 US$27,370
2019-03-06 2019-03-05
US Precigen Inc (PGEN)
S Sale
2,300 -5.2%
4.66
US$10,718 		2,300 -5.2% 4.66 US$10,718
2019-03-06 2019-03-04
US Precigen Inc (PGEN)
S Sale
44,000 -50.0%
4.22
US$185,680 		44,000 -50.0% 4.22 US$185,680
2019-03-06 2019-03-04
US Precigen Inc (PGEN)
S Sale
165,000 -65.2%
4.17
US$688,050 		165,000 -65.2% 4.17 US$688,050
2019-03-06 2019-03-04
US Precigen Inc (PGEN)
S Sale
16,500 -20.8%
4.24
US$69,960 		16,500 -20.8% 4.24 US$69,960
2019-01-04 2019-01-03
US Precigen Inc (PGEN)
PlS Planned sale
2,944 -3.6%
7.07
US$20,816 		2,944 -3.6% 7.07 US$20,816
2019-01-03 2018-12-31
US Precigen Inc (PGEN)
S Sale
30,000 -29.2%
6.36
US$190,671 		30,000 -29.2% 6.36 US$190,671